Literature DB >> 28302934

Hepatitis B Vaccination Status among Japanese Travelers.

Kenichiro Yaita1, Koji Yahara2, Yoshiro Sakai1,3, Jun Iwahashi1, Kenji Masunaga1, Nobuyuki Hamada1, Hiroshi Watanabe1.   

Abstract

This study clarified the characteristics of travelers who received hepatitis B vaccinations. Subjects were 233 Japanese travelers who visited our clinic prior to travel. We summarized the characteristics of the clients and performed two comparative studies: first, we compared a hepatitis B-vaccinated group with an unvaccinated group; second, we compared a group that had completed the hepatitis B vaccine series with a group that did not complete the series. The hepatitis B vaccine was administered to 152 clients. Factors positively associated with the hepatitis B vaccination (after adjusting for age and sex) included the following: travel for business or travel as an accompanying family member; travel to Asia; travel for a duration of a month or more; and, inclusion of the vaccine in a company or organization's payment plan. Meanwhile, factors negatively associated with the vaccination were travel for leisure or education, and travel to North America or Africa. Among 89 record-confirmed cases, only 53 completed 3 doses. The completion rate was negatively associated with the scheduled duration of travel if it was from a month to less than a year (after adjusting for age and sex). The present study provides a basis for promoting vaccination compliance more vigorously among Japanese adults.

Entities:  

Keywords:  Japanese travelers; completion rate; hepatitis B vaccine; pre-travel consultation

Mesh:

Substances:

Year:  2017        PMID: 28302934     DOI: 10.2739/kurumemedj.MS00018

Source DB:  PubMed          Journal:  Kurume Med J        ISSN: 0023-5679


  1 in total

1.  Typhoid Vaccination among Japanese Travelers to South Asia and the Factors Associated with Compliance.

Authors:  Kenichiro Yaita; Koji Yahara; Nobuyuki Hamada; Yoshiro Sakai; Jun Iwahashi; Kenji Masunaga; Hiroshi Watanabe
Journal:  Intern Med       Date:  2017-12-27       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.